Skip to main content
Log in

Effectiveness of rhGH treatment on final height of renal-transplant recipients in childhood

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Growth retardation is a considerable clinical problem in children with chronic kidney disease (CKD). Optimization of metabolic and nutritional parameters does not always lead to improved growth. Recombinant human growth hormone (rhGH) treatment has been used to improve height. Several studies in the literature have shown increased growth velocity, although data on the final height (FH) reached are scarce.

Aims

We assessed the effect of rhGH on FH standard deviation score (SDS) in children with CKD following renal transplantation (RTx), comparing it with patients who did not receive rhGH (control group) but were treated with the same protocol and followed up in a single Center.

Methods

Thirty-three patients received rhGH treatment until FH. Fourteen who refused rhGH therapy were included in the controls. Prognostic factors for FH and changes in glomerular filtration rate (GFR) during follow-up were also analyzed

Results

FH SDS in rhGH-treated patients was significantly higher than in controls (−1.88 ± 1.14 vs −3.48 ± 1.19 SDS, respectively, p <0.05). In both groups, a similar reduction in GFR was observed. Height (SDS) at onset of rhGH treatment was the only statistically significant variable useful to predict response to treatment (p = 0.001).

Conclusion

Our findings confirm that rhGH is effective to improve FH in CKD RTx patients, without affecting kidney function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Seikaly MG, Salhab N, Gipson D, Yiu V, Stablein D (2006) Stature in children with chronic kidney disease: analysis of NAPRACS database. Pediatr Nephrol 21:793–799

    Article  PubMed  Google Scholar 

  2. Hokken-Koelega AC, Stijnen T, de Ridder MA, de Muinck Keizer-Schrama SM, Wolff ED, Jong MC, Donckerwolcke RA, Groothoff JW, Blum WF, Drop SL (1994) Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet 28:343(8909):1313-1317

  3. Hokken-Koelega AC, Stijnen T, De Jong MC, Donckerwolcke RA, De Muinck Keizer-Schrama SM, Blum WF, Drop SL (1994) Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency. J Clin Endocrinol Metab 79:1185–1190

    Article  PubMed  CAS  Google Scholar 

  4. Powell DR, Liu F, Baker BK, Hintz RL, Lee PD, Durham SK, Brewer ED, Frane JW, Watkins SL, Hogg RJ (1997) Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group. Kidney Int 51:1970–1979

    Article  PubMed  CAS  Google Scholar 

  5. Hokken-Koelega A, Mulder P, De Jong R, Lilien M, Donckerwolcke R, Groothof J (2000) Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency. Pediatr Nephrol 14:701–706

    Article  PubMed  CAS  Google Scholar 

  6. Hokken-Koelega AC, Stijnen T, de Jong RC, Donckerwolcke RA, Groothoff JW, Wolff ED, Blum WF, de Muinck Keizer-Schrama SM, Drop SL (1996) A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant. Kidney Int Suppl 53:S128–S134

    PubMed  CAS  Google Scholar 

  7. Guest G, Berard EH, Crosnier H, Chevallier T, Rappaport R, Broyer M (1998) Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Nephrology, Pediatr transplantation. French Society of Pediatric Nephrology. Pediatr Nephrol 12:437–446

    Article  PubMed  CAS  Google Scholar 

  8. Maxwell H, Rees L, British Association for Pediatric Nephrology (1998) Randomized controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. Arch Dis Child 79:481-487

    Google Scholar 

  9. Fine RN, Stablein D, Cohen AH, Tejani A, Kohaut E (2002) Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS. Kidney Int 62:688–696

    Article  PubMed  CAS  Google Scholar 

  10. Haffner D, Schaefer F, Nissel R, Wühl E, Tónshoff B, Mehls O, German Study Group for growth hormone treatment in chronic renal failure (2000) Effect of growth hormone treatment on the adult height of children with chronic renal failure. N Engl J Med 343:923–930

    Article  PubMed  CAS  Google Scholar 

  11. Fine R, Stablein D (2005) Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry. Pediatr Nephrol 20:404–408

    Article  PubMed  Google Scholar 

  12. Seikaly M, Waber P , Warady B , Stablein D (2009) The effect of rhGH on height velocity and BMI in children with CKD: a report of the NAPRTCS registry. Pediatr Nephrol 24:1711–1717

    Google Scholar 

  13. Tanner JM, Whitehouse RH, Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children. Arch Dis Child 219:454–471

    Article  Google Scholar 

  14. Guerlich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist. Stanford University Press, Stanford, California

    Google Scholar 

  15. Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571–590

    PubMed  CAS  Google Scholar 

  16. Kopple JD, Hirschberg R (1990) Physiological effects of growth hormone and insulin-like growth factor I on the kidney. Miner Electrolyte Metab 16:82–88

    PubMed  CAS  Google Scholar 

  17. Nissel R, Lindberg A, Mehls O, Haffner D, Pfizer International Growth Database (KIGS) International Board (2008) Factors predicting the near-final height in growth hormone-treated children and adolescents with chronic kidney disease. J Clin Endocrinol Metab 93:1359–1365

    Article  PubMed  CAS  Google Scholar 

  18. Bérard E , André JL, Guest G , Berthier F,l Afanetti A, Cochat P, Michel Broyer M (2008) On behalf of the French Society for Pediatric Nephrology. Long-term results of rhGH treatment in children with renal failure: experience of the French Society of Pediatric Nephrology. Pediatr Nephrol 23:2031–2038

    Google Scholar 

Download references

Acknowledgments

Supported by grants from Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Fondo para la Investigación Científica y Tecnologica (FONCYT), Argentina

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alicia Belgorosky.

Additional information

Elisa Vaiani and Gabriela Guercio share second authorship of the article

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gil, S., Vaiani, E., Guercio, G. et al. Effectiveness of rhGH treatment on final height of renal-transplant recipients in childhood. Pediatr Nephrol 27, 1005–1009 (2012). https://doi.org/10.1007/s00467-011-2090-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-011-2090-8

Keywords

Navigation